The study found no mean difference in all-cause healthcare costs for patients with newly diagnosed nonvalvular atrial fibrillation initiating treatment with dabigatran versus warfarin.
Stephen D. Sander, PharmD
Advertisement
Articles by Stephen D. Sander, PharmD
Advertisement
Latest Updated Articles
- Predictors of Healthcare Costs After Initiating Dabigatran Versus Warfarin
Published: February 2nd 2018 | Updated:
Advertisement
Advertisement
Trending on Pharmacy Times
1
Exercise Program Manages Persistent Symptoms Post-COVID-19 Infection
2
FDA Approves IsoPSA Blood Test to Detect Prostate Cancer
3
The Unit-Based Pharmacist: Roles, Responsibilities, and Real Impact
4
Yale Study Finds Association Between Chronic Hepatitis C and Pancreatic Cancer
5
